Source: Medical Device Network

Omron Healthcare: OMRON receives FDA authorisation for blood pressure monitors with AFib feature

OMRON Healthcare has secured De Novo authorisation from the FDA for new home blood pressure monitors with AI-powered AFib. The post OMRON receives FDA authorisation for blood pressure monitors with AFib feature appeared first on Medical Device Network.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
250-500
Ranndy Kellogg's photo - President & CEO of Omron Healthcare

President & CEO

Ranndy Kellogg

CEO Approval Rating

84/100

Read more